Discover Great Companies Discover Great Clients
Popularity  11.1万   |   Followers  76   |   Likes  45   |   Feedback  59 Claim this company

A comprehensive pharmaceutical enterprise integrating drug R&D, produc

No.80 Chengdu City Popularity Ranking No.29 High-tech Zone No.110 Sichuan Pr No.1 Research Institute No.1 Gong Yi Design No.1 Fine Chemicals No.1 Chemistry APIs No.2 Chemical Raw Materials No.2 Sheng Ming Ke Xue No.2 Lin Chuang Yan Jiu No.3 Pharmaceutical R&D No.3 Zhong Jian Ti No.3 Pharmaceutical Intermediates No.4 Ke Xue Yan Jiu No.4 Gong Cheng Yan Jiu Center 企业技术中心 博士后工作站 国家高新技术企业 高新技术企业 国家企业技术中心 省著名商标 药品生产许可证 NMPA认证
More

Company Overview

  • Nature: Listed Company Size: 1000-4999 employees Founded: 17年
  • Industry: Pharmaceutical/Biotechnology 、 Raw Materials and Processing 、 Academic/Scientific Research
  • Full name: Chengdu Yuandong Bio-Pharmaceutical Joint-Stock Co., Ltd.。

Development Stage

  • Stage: IPO上市, , 上交所。
  • Ranking: Ranked #80 in Chengdu City by popularity Ranked #1 in Chengdu Research Institute Company by popularity Ranked #1 in Chengdu Gong Yi Design Company by popularity Ranked #1 in Chengdu Fine Chemicals Company by popularity Ranked #1 in Chengdu Chemistry APIs Company by popularity
  • Honors: 2022中国高新技术企业慈善公益500强 2025中国化药研发实力100强 企业技术中心 博士后工作站 According to algorithm
  • News: 2026-05-22:苑东生物:维生素K1注射液获得药品注册证书。
  • Salary: 62.1% of positions earn 10-30K, In 2026 vs last yeargrew by 8%.。Master's salary: ¥25.9K, Doctorate salary: ¥42.0K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 16.9%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 10.6%, "Computer/Network/Technology": 7.5%。
  • Recruiting: In 2026 vs 2025grew by 116%. Demand for highly educated talent: Master's: 34, Doctorate: 12.
  • Requirement: Education: 大专 leads with 48.8%. Experience: 1-3年 leads with 41.6%.
  • Region: Distributed across 15 regions, 成都: 35.6%, 上海: 14.8%, 北京: 6%, 广州: 3.4%.

About the Company

[Summary] A comprehensive pharmaceutical enterprise integrating drug R&D, produc

Chengdu Yuandong Bio-Pharmaceutical Joint-Stock Co., Ltd. is a high-tech enterprise driven by R&D and innovation, integrating the R&D, production, and sales of chemical APIs, high-end chemical drugs, and biological drugs. Founded in 2009, the company has 7 wholly-owned subsidiaries and currently employs over 1,400 people. The company was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange in September 2020 (Stock Short Name: Yuandong Bio-Pharmaceutical, Stock Code: 688513).
Yuandong Bio-Pharmaceutical has always adhered to the corporate mission of "Patient-centered, bringing sunshine to human health," and through continuous technological innovation, has gradually established R&D technology and industrialization platforms that meet domestic and international standards. The company strategically focuses on the anesthesia and analgesia field while also covering major disease areas such as cardiovascular and cerebrovascular diseases, oncology, pediatric drugs, and endocrinology. It has successfully industrialized over 30 chemical drug formulation products and over 20 chemical API products. Among the marketed formulation products, 5 are the first generic drugs in China, 24 have passed consistency evaluation, and 9 products have been selected for national centralized drug procurement. Among the company's API products, over 10 chemical APIs have been exported to the international market.
Driven by R&D and innovation, Yuandong Bio-Pharmaceutical has consistently maintained a high proportion of R&D investment to build core R&D competitiveness (average R&D investment over the past three years: 20%). The company's R&D center has established multiple research platforms, including the National Enterprise Technology Center, Postdoctoral Research Station, and Sichuan Provincial Drug Solid-State Engineering Technology Research Center. It has built key technology platforms such as drug crystal form technology, sustained and controlled release technology, special drug technology, innovative drug technology, and clinical trial platforms. The company possesses six major core technologies, including drug crystal form integrated innovation and industrialization technology, innovative compound structure design, synthesis and evaluation integration technology, sustained and controlled release technology and delayed release technology, nasal spray drug delivery technology, preparation process design and lean control technology, and mRNA raw material synthesis technology. The company has assembled a diversified, internationalized, and professional R&D team. With its core R&D strength, the company has led 2 National Key R&D Projects and 5 National Major New Drug Innovation Projects, cumulatively undertaken over 50 national and provincial/ministerial projects, and obtained nearly 100 authorized domestic and international invention patents, including 15 international patents. In its focus areas, Yuandong Bio-Pharmaceutical has laid out over 60 R&D projects with a global perspective, with innovative drug projects accounting for approximately 16%. Five innovative drug projects are currently undergoing Phase I to Phase III clinical trials. Additionally, multiple ANDA high-end formulation varieties have been laid out, with 2 high-end injection projects accepted by the FDA.
Yuandong Bio-Pharmaceutical has established a mature and comprehensive marketing system with a nationwide marketing network and a professional academic promotion team, ensuring sustained growth in the company's sales scale.
Yuandong Bio-Pharmaceutical attaches great importance to quality control. Its APIs have passed FDA on-site inspections, EU certification, and audits from multiple customers in the United States and Japan. The internationalized R&D and production base - Shuode Pharmaceutical, built in accordance with NMPA, EMEA, and FDA regulatory requirements, has obtained the "Drug Manufacturing License" for multiple production lines.
Yuandong Bio-Pharmaceutical has received honors such as "National Technology Innovation Demonstration Enterprise," "National Green Factory," "National Intellectual Property Demonstration Enterprise," "Outstanding Enterprise in the Pharmaceutical Industry for the 70th Anniversary of the Founding of New China," "China Pharmaceutical R&D Product Line Industrial Enterprise," "China Pharmaceutical Industry Growth Enterprise," and "Sichuan Provincial Science and Technology Progress Second Prize." It has also ranked on lists such as "Top 100 China Pharmaceutical Innovation Enterprises," "Top 20 China Chemical Drug R&D Strength," "Top 50 China Drug R&D Comprehensive Strength," "Top 100 China Chemical Drug Enterprises," and "Top 100 STAR Market Listed Companies."
Yuandong Bio-Pharmaceutical always upholds the values of "Sunshine, Value, Innovation, and Efficiency," with the vision of "Serving the public, achieving self-fulfillment, and becoming the most respected and trusted pharmaceutical enterprise." The company aspires to become a global leader in the anesthesia and analgesia field. In the future, the company will accelerate the implementation of technological innovation and internationalization strategies, adhere to the strategic path of focusing on small molecule innovative drugs and developing biological drugs, take meeting clinical needs as its responsibility, provide patients with more, safer, and more effective high-end chemical and biological drugs, and bring sunshine to human health.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Yuandong Bio-Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal: 上交所

Yuandong Bio-Pharmaceutical How Fast Is Hiring Growing? (261 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 77%
  • 2024: Down 48%
  • 2023: Up 113%
  • 2022: Down 46%
Yuandong Bio-Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Yuandong Bio-Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Graduates 9 Interns 10 Master's 34 Doctorate 12
No.188
Company Recruitment Ranking in Chengdu City 򀀩
No.495
Recruitment Growth Ranking in Chengdu City 򀀩
No.41
Graduate Talent Ranking in Chengdu City 򀀩
No.14
Intern Talent Ranking in Chengdu City 򀀩
Note: How fast is hiring at Chengdu Yuandong Bio-Pharmaceutical Joint-Stock Co., Ltd. growing? Yuandong Bio-Pharmaceutical2026: 473 openings (up 116%), 2025: 219 openings (up 77%), 2024: 124 openings (down 48%), 2023: 238 openings (up 113%), 2022: 112 openings (down 46%), 2021: 209 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Yuandong Bio-Pharmaceutical Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Chengdu Yuandong Bio-Pharmaceutical Joint-Stock Co., Ltd. growing? . Yuandong Bio-Pharmaceutical master talent ranking in Chengdu: #28, Yuandong Bio-Pharmaceutical master salary mostly around 20-50K.

Yuandong Bio-Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
-21%
Growth Rate
2026 vs 2025
  • 2025: Up 533%
  • 2024: Down 50%
  • 2023: Down 25%
  • 2022: Down 20%
Yuandong Bio-Pharmaceutical Doctoral Hiring by Year: 2026 — 4 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Chengdu Yuandong Bio-Pharmaceutical Joint-Stock Co., Ltd. growing? Yuandong Bio-PharmaceuticalDoctorate recruitment over the years: 2026: 15 openings (down 21%), 2025: 19 openings (up 533%), 2024: 3 openings (down 50%), 2023: 6 openings (down 25%), 2022: 8 openings (down 20%), 2021: 10 openings. Yuandong Bio-Pharmaceutical doctorate talent ranking in Chengdu: #24, Yuandong Bio-Pharmaceutical doctorate salary mostly around 30-50K and above.

Yuandong Bio-Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Chengdu Yuandong Bio-Pharmaceutical Joint-Stock Co., Ltd.? Based on an analysis of Yuandong Bio-Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 16.9%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 10.6%, "Computer/Network/Technology": 7.5%, "Other (R&D and Technical)": 4.8%, "Scientific Research": 4.1%, "Electrical/Energy/Power": 0.7%. For reference only.

Yuandong Bio-Pharmaceutical — What Are the Salaries Like? (416 records)

Manage
Yuandong Bio-Pharmaceutical Salary Overview
salary range: 6K - 50K, 62.1% of roles pay ¥10-30K
Note: salary statistics are based on 416 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Chengdu Yuandong Bio-Pharmaceutical Joint-Stock Co., Ltd.?Yuandong Bio-Pharmaceutical62.1% of positions earn 10-30K, Fresh graduate salary: ¥14.8K。Chengdu salary ranking top 15,Sales average salary ¥17.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Yuandong Bio-Pharmaceutical

(More)
Are salaries high at Chengdu Yuandong Bio-Pharmaceutical Joint-Stock Co., Ltd.? We provide: Pharmaceutical Sales Representative, 临床, Regional Manager, Retail, Researcher, Product Manager, Key Account Manager, Regional Director, Medical Manager, Promotion Specialist, Sales, Product Manager, Leasing Manager, Operations, Project Manager, RA, Intern, Technical Manager, Construction Worker, Software Implementation. Click to view detailed salary analysis by job.

Yuandong Bio-Pharmaceutical — Fortune 500? (More)

Yes, ranked in 中国高新技术企业慈善公益500强:

  • NO.118 2022中国高新技术企业慈善公益500强 >

Yes, ranked in 中国化药研发实力100强:

  • NO.31 2025中国化药研发实力100强 >
  • NO.39 2024中国化药研发实力100强 >

Job Category

  • Sales
    52% of total 52%
  • Medical & Health/Beauty & Healthcare
    18.4% of total 18.4%
  • Business Management
    17.4% of total 17.4%
  • Biology/Pharmaceutical/Chemical/Environmental Protection
    13% of total 13%

Education

  • 大专
    48.8% of total 48.8%
  • 本科
    34.2% of total 34.2%
  • 硕士
    13% of total 13%
  • 博士
    3% of total 3%

Experience

  • 1-3年
    41.6% of total 41.6%
  • 不限
    24% of total 24%
  • 3-5年
    18.6% of total 18.6%
  • 5-10年
    12.4% of total 12.4%
View Detailed Analysis

What does Chengdu Yuandong Bio-Pharmaceutical Joint-Stock Co., Ltd. require? Who is Yuandong Bio-Pharmaceutical hiring? Yuandong Bio-Pharmaceutical recruitment: Sales占比最多占52%,其次是Medical & Health/Beauty & Healthcare占18.4%. What education can get in at Yuandong Bio-Pharmaceutical? 大专占比最多占48.8%,其次是本科占34.2%. High education required at Yuandong Bio-Pharmaceutical? 硕士占13%,博士占3%. Work experience required at Yuandong Bio-Pharmaceutical? 1-3年占比最多占41.6%,其次是不限占24%. Where are the job locations at Yuandong Bio-Pharmaceutical? 成都占比最多占35.6%,其次是上海占14.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 17,653.2256万(元)
Legal Representative: 王颖
Date Established:
Credit Code: 91510100689030428K
Registered Address: 成都高新区西源大道8号

Partners & Suppliers

2022年与苑东生物签署战略合作协议,针对高端化学药研发外包 Source
供应商 化学药工艺开发与生产
提供年度审计服务 Source
供应商 审计服务
药品配送与分销 Source
合作客户 医药商业分销
药品配送与分销 Source
合作客户 医药商业分销
药品配送与分销 Source
合作客户 医药商业分销

People who follow Yuandong Bio-Pharmaceutical also follow

Yuandong Bio-Pharmaceutical Competitors (Similar Companies)

“Creating value for car owners' vehicle use and life”
“Optical module solutions and service provider”
“中国家电标委会电热毯分技术委员会秘书长”
“Caring for life, maintaining health”
“Let everyone have trust and expectation in Baili because of health!”
“Products for the diagnosis and treatment of allergic diseases”
“Focused on green lighting”
医药 生物医药 单克隆抗体药物 高通量筛选
“Create delicious products, spread the taste of happiness”
“高端装备制造+环境综合服务商”
“Leading efficient planting, empowering modern agriculture”
“Managing health, creating brightness”
“Home furnishing brand operator”
“供应链管理及综合物流服务商”
制冷 压缩机 精密铸造 空调压缩机

Discover Great Companies, Discover Great Clients

成都公司名录 成都“High-tech Zone”公司名录 成都“制药/药业”公司名录 成都“医药”公司名录 成都“医药中间体”公司名录 成都“抗肿瘤药”公司名录 成都“生物制药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates